Skip to main content
Callitas Health Inc. logo

Callitas Health Inc. — Investor Relations & Filings

Ticker · MPHMF ISIN · CA13125C1068 LEI · 529900HKC30J5TGKHE19 CSE Manufacturing
Open in API
Filings indexed 294 across all filing types
Latest filing 2021-04-08 Regulatory Filings
Country CA Canada
Listing CSE MPHMF

About Callitas Health Inc.

https://www.callitas.com

Callitas Health Inc. is a clinical-stage biomedical technology company focused on developing and commercializing innovative technologies for both pharmaceutical and over-the-counter (OTC) markets. The company's development pipeline targets therapeutic areas such as obesity, weight management, and female health and wellness. Callitas also explores technologies related to CBD/Cannabis delivery, including CannaMint Strips. It provides consumer health and wellness products in the United States and Canada, emphasizing the application of pharmaceutical best practices to its OTC offerings.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Callitas Health Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2020. The document is primarily a certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is short (2999 characters), consistent with a certification letter rather than a full report.
2021-04-08 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CEO of Callitas Health Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2020. The content is primarily an officer certification letter regarding the interim filings, not the filings themselves. It explicitly states it is a certification and does not contain actual financial data or substantive financial analysis. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR). The document length is short (2975 characters), consistent with a certification letter rather than a full report.
2021-04-08 English
Interim MD&A - English.pdf
Regulatory Filings
2021-04-08 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-04-08 English
Interim financial statements/report – English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution (Non-investment fund issuer)' and contains detailed information about securities distribution, including issuer details, distribution dates, purchaser information, types of securities distributed, and compensation related to the distribution. It is a regulatory filing related to exempt distributions under Canadian securities law, specifically Form 45-106F1, which is a report filed with securities regulators to disclose exempt distributions of securities. The document does not contain financial statements, management discussion, or earnings data, nor is it an announcement or presentation. It is a regulatory compliance filing reporting on securities distribution activities. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2020-09-22 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Consolidated Financial Statements (Unaudited)' for the period ended June 30, 2020. It contains detailed financial statements including the statement of financial position, comprehensive loss, changes in equity, cash flows, and accompanying notes. The document references compliance with IAS 34 - Interim Financial Reporting, which is the standard for interim financial reports. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full interim financial report, not just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-09-22 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.